جستجوی استاد راهنمای دانشگاهی

Dr. Ahmet Acar is an Associate Professor at the Department of Biological Sciences, Middle East Technical University (METU), Ankara, Turkey. He leads the Cancer Precision Medicine and Drug Resistance Laboratory, focusing on understanding mechanisms of drug resistance in cancer. His research integrates experimental models, next-generation sequencing, and deep learning to address clinical challenges in cancer therapy. Dr. Acar holds a B.Sc. from METU's Biological Sciences department and a Ph.D. from the Cancer Research UK Manchester Institute. He completed postdoctoral training at the Institute of Cancer Research, London, and the University of Manchester. Research Interests: Drug resistance mechanisms, precision oncology, tumor microenvironment modeling, patient-derived organoids, computational pathology, and evolutionary cancer biology. His lab develops 2D/3D co-culture systems, PDO biobanks, and AI-driven histopathology tools to improve treatment strategies. Recent Work Trends: Recent publications emphasize tumor evolution modeling, matrix mechanics in drug resistance, and AI applications in histopathology. Collaborations with hospitals in Turkey and Europe support PDO biobank initiatives. His team explores evolutionary steering strategies to exploit collateral drug sensitivities. Labs/Teams: Precision Medicine and Drug Resistance Lab at METU focuses on interdisciplinary approaches combining wet-lab experiments with computational methods. Current projects include ex vivo tumor modeling and AI-driven diagnostic tools for oncology.

• Cancer Biology
• Precision Medicine
• Drug Resistance Mechanisms
• +۳ مورد دیگر

Prof. Abdullah Erdem Canda is a Professor of Urology at Koç University School of Medicine and leading robotic surgery specialist. He serves on the Board of the European Robotic Urology Society (ERUS) and trains surgeons internationally. Clinical expertise includes robot-assisted procedures for prostate, kidney, and bladder cancers. He developed novel techniques for intracorporeal neobladder reconstruction and has performed over 800 robotic surgeries. Awarded multiple prizes by ERUS for research innovations in urologic oncology.

• Robotic Surgery
• Urologic Oncology
• Prostate Cancer
• +۱ مورد دیگر

Prof. Dr. Deniz Tural is a faculty member at Koç University Hospital, Medical Oncology since 2024. He previously held academic positions at the University of Health Sciences (2022) and Bakırköy Education and Research (2015). His expertise spans clinical trials and oncology. Education: Medical Education at Istanbul University Cerrahpasa Faculty of Medicine (1996-2002) Internal Medicine Doctor at Şişli Etfal Education Research (2003-2009) Medical Oncology at Akdeniz University Faculty of Medicine (2013-2015) Medical Oncology at Bakırköy Dr. Sadi Konuk Education Research (2016-2024) Clinical Interests: Focus on immunotherapy, targeted therapies, and cancers of the prostate, bladder, renal, and testis. Led 30 Phase III clinical trials in oncology. Scientific Awards: ESMO Certificate of Proficiency Turkish Society of Medical Oncology Certificate of Proficiency Affiliations: Member of ASCO, ESMO, and Turkish Society of Medical Oncology. Active in international and domestic clinical research collaborations.

• Oncology
• Immunotherapy
• Targeted Therapies
• +۵ مورد دیگر

Buse Cevatemre is a Research Fellow at Koç University specializing in anticancer drug development and epigenetic therapies. Her work focuses on overcoming chemoresistance in triple-negative breast and lung cancers through epigenetic targets like BRPF1 and LSD1. Research employs chemical biology approaches including chromatin-focused screens, metal complex synthesis, and combination therapy strategies. Key research areas include: mechanism-based anticancer drug design, apoptosis induction pathways, cancer stem cell targeting, and metabolic regulation of drug resistance. Recent studies investigate ribosomal pathway modulation in taxane resistance and dual epigenetic inhibition strategies. Publications (2018-2025) demonstrate expertise in metallodrug chemistry (Pt, Cu, V complexes), epigenetic vulnerability identification, and resistance mechanism elucidation. Methodologies span complex synthesis, epigenetic screening, apoptosis assays, and molecular pathway analysis across various cancer models.

• Anticancer Drug Development
• Cell Death Mechanisms
• Cancer Stem Cells
• +۲ مورد دیگر

Assoc. Prof. Dr. Gülsüm Seda Güleç Yılmaz is an Associate Professor at Yeditepe University Faculty of Medicine, Department of Medical Biology. With a PhD in Molecular Medicine from Yeditepe University (2016), she specializes in genetic polymorphisms, oxidative stress, and biomarker discovery in cardiovascular and oncological contexts. Education : PhD in Molecular Medicine (2016), MSc in Histology & Embryology (2005), BSc in Biology (2002) Research Focus : DNA repair mechanisms, microRNA profiling, genetic susceptibility in atherosclerosis, prostate/glioma/ovarian cancers, and vitamin D receptor polymorphisms Her 15 most recent publications (2013-2024) center on genetic polymorphisms in diseases like ovarian cancer, atherosclerosis, and neurodegenerative disorders. Key methodologies include next-generation sequencing , PCR-RFLP , and microRNA analysis . Collaborative work spans cardiovascular research , oncology , and neurogenetics . Scientific Awards : Bilime Katkı Ödülü (Istanbul University) Best Oral Presentation Award - First Place (Heart and Health Foundation of Turkey) Best Oral Presentation Award - Second Place (Turkish Neurosurgery Association) As a supervisor, she has guided 15+ thesis students (Master's and Doctoral levels) in genetic studies related to cancers and metabolic disorders. Her work on lipoprotein subfractions and oxidative stress markers continues to advance precision medicine applications.

• Molecular Medicine
• Medical Genetics
• DNA Repair
• +۵ مورد دیگر

Mehmet Çayören is a Professor at Istanbul Technical University in the Department of Electronics and Communication Engineering. His research focuses on applying microwave imaging techniques to medical diagnostics, particularly for early detection of breast cancer. He leads the development of the SAFE (Screening and Early Detection) microwave imaging system, which has shown promising results in clinical investigations. His work bridges electrical engineering, biomedical applications, and machine learning for improved cancer screening. Dr. Çayören's research interests span multiple domains within electromagnetic applications for medical imaging: Microwave imaging systems for breast cancer detection and screening Determination of dielectric properties of biological tissues Development of open-ended coaxial probe techniques for material characterization Application of machine learning algorithms (XGBoost, SVM) to enhance medical imaging Monitoring of intracerebral hemorrhage using microwave imaging Development of tissue-mimicking phantoms for medical device validation His recent publications demonstrate a strong trend toward integrating advanced machine learning techniques with microwave imaging systems to improve diagnostic accuracy. The SAFE platform represents a significant advancement in non-invasive breast cancer screening, particularly for dense breast tissue where traditional mammography has limitations. His work also extends to neurological applications, with research on microwave-based monitoring of brain hemorrhages. Scientific awards received by Dr. Çayören include: Teknoloji Ödülü (Technology Award) in 2014 Dr. Çayören has supervised 24 students and leads multiple research projects funded by various sources including TUBITAK. His current projects focus on microwave imaging systems for breast cancer screening, monitoring of intracerebral hemorrhage, and hardware design for microwave imaging systems. He collaborates extensively with medical professionals to validate his imaging systems in clinical settings. Dr. Çayören leads a research group focused on microwave imaging applications in medicine. His team develops both hardware systems (like the SAFE platform) and advanced signal processing algorithms to improve medical diagnostics. The group maintains close collaborations with hospitals for clinical validation of their imaging systems.

• Microwave Imaging
• Dielectric Properties
• Antenna Engineering
• +۵ مورد دیگر

Prof. Dr. Ali Coruh is a distinguished faculty member at Sakarya University 's Faculty of Science, Department of Physics , where he has served as Head of the General Physics Department since 2022. With a career spanning over three decades, his expertise lies in Condensed Matter Physics , Nanotechnology , and Materials Science , focusing on perovskite oxides , adsorbent materials , and supercapacitor applications . PhD in Physics, Middle East Technical University (2003) MSc in Physics, Sakarya University (1996) BSc in Physics, Karadeniz Technical University (1989) His research interests include computational modeling of molecular structures, environmental pollutant removal using nanomaterials, and electrochemical properties of advanced materials. Recent studies focus on pharmaceutical pollutant recovery via organoclay composites, Pd-doped perovskites for biosensing, and perovskite oxides for energy storage. His work bridges theoretical and experimental approaches in solid-state physics and environmental remediation . The article trends show consistent contributions to Journal of the Taiwan Institute of Chemical Engineers , Chemical Engineering Journal , and Journal of Energy Storage , with a focus on adsorption mechanisms , electrocatalysis , and nanocomposite synthesis . Collaborations span international institutions, including studies on supercapacitor electrode materials and microwave absorbing textiles . As an academic leader, he has supervised 14 doctoral and master's theses , including works on molecular dynamics , perovskite oxides , and nanoparticle-based sensors . He has also served on editorial boards for journals like Materials Chemistry and Physics (2010-2013) and contributed to TUBITAK Olympiad training .

• Condensed Matter Physics
• Nanotechnology
• Materials Science
• +۳ مورد دیگر

Professor Tülay Kuş is a distinguished faculty member at Gaziantep University Faculty of Medicine, Department of Internal Medicine, specializing in Medical Oncology. She currently holds the position of Professor after previously serving as Associate Professor since 2020. Her extensive academic and clinical career spans multiple prestigious institutions including Gaziantep University, Adıyaman University, and Dr. Ersin Arslan Education and Research Hospital. Dr. Kuş completed her medical education at Kocaeli University Faculty of Medicine (1999-2006), followed by medical specialization at Gaziantep University Faculty of Medicine, Department of Internal Medicine (2006-2011 and 2013-2016). Her educational background reflects a strong foundation in internal medicine with specialized focus on oncology. Her research interests span multiple areas of oncology including immunotherapy, molecular targeted therapies, breast cancer, lung cancer, gastrointestinal tumors, gynecological oncology, and radioligand therapy. Dr. Kuş has made significant contributions to the field through her extensive publication record and book chapters on cutting-edge cancer treatments. Analysis of her 15 most recent publications (2022-2024) reveals a strong focus on precision oncology approaches, including molecular biomarkers (KRAS, STK11, KEAP1), advanced imaging techniques (FAPI PET/CT), radioligand therapies (PSMA-targeted), and critical evaluation of clinical trial methodologies. Her work demonstrates expertise across multiple cancer types with particular emphasis on breast, lung, prostate, and gastrointestinal cancers. Scientific Awards 2016 Mesleki Dernekler en iyi sözel bildiri ödülü - Anatolian Medical Oncology Association 2015 Professional Associations Best Oral Presentation - Anatolian Medical Oncology Association Dr. Kuş has successfully supervised multiple graduate students, with completed theses focusing on nivolumab efficacy in lung cancer, imatinib treatment in gastrointestinal stromal tumors, and genetic testing perspectives in breast and ovarian cancer. Her extensive professional development includes participation in numerous national and international oncology courses covering head and neck cancers, hematological malignancies, thoracic oncology, neuroendocrine tumors, and colorectal cancer through institutions including the University of Oxford. She maintains active membership in the Turkish Medical Oncology Association and has contributed significantly to the field through her research, teaching, and clinical practice in medical oncology.

• Medical Oncology
• Immunotherapy
• Molecular Targeted Therapies
• +۷ مورد دیگر

Prof. Dr. Dilek Telci is a Professor at Yeditepe University, Faculty of Engineering, Department of Genetics and Bioengineering. She has been with Yeditepe University since 2008, progressing from Assistant Professor to Associate Professor in 2012, and to Professor in 2018. Her academic journey includes a PhD from The Nottingham Trent University (2001-2005), Master's Degree from Brunel University (1999-2001), and undergraduate studies at Middle East Technical University (1994-1999). Dr. Telci's research spans cancer biology, molecular biology, genetics, and bioengineering, with special expertise in tissue transglutaminase, drug delivery systems, and nanomedicine applications for cancer treatment. Her work has significantly advanced understanding of how tissue transglutaminase influences cancer progression, particularly in renal cell carcinoma and prostate cancer. She has pioneered the development of poly(2-ethyl-2-oxazoline) (PEtOx) based nanocarriers for targeted cancer therapy, creating innovative systems that selectively deliver therapeutic agents to tumor cells while minimizing effects on healthy tissue. Analysis of her recent publications reveals a strong focus on developing targeted therapies for prostate and breast cancers using advanced nanocarrier systems. Her research combines molecular biology with pharmaceutical sciences to create novel approaches that address key challenges in cancer treatment, including drug resistance, metastasis, and treatment toxicity. Her work spans from basic molecular mechanisms to translational applications, demonstrating a comprehensive approach to cancer research. Dr. Telci has secured multiple competitive research grants from TUBITAK and other funding agencies, demonstrating the significance and impact of her work. She actively supervises numerous graduate students, guiding research in cancer genetics, stem cell biology, and drug delivery systems. Her laboratory is a hub for interdisciplinary cancer research, combining molecular biology, nanotechnology, and pharmaceutical sciences to develop next-generation cancer therapies.

• Cancer Biology
• Molecular Biology
• Genetics
• +۵ مورد دیگر

Assoc. Prof. Dr. Zihni Onur UYGUN serves as an Associate Professor in the Department of Biochemistry at Ege University's Faculty of Medicine, Turkey. His research pioneers electrochemical biosensor technologies for advanced medical diagnostics, focusing on label-free detection systems integrating nanomaterials and molecular recognition elements. His academic journey includes: PhD in Medical Biochemistry (Ege University, 2016-2020) PhD in Biotechnology (Kafkas University, 2025) Postdoctoral Research (Clarkson University, USA, 2023-2024) Postdoctoral Research (Koç University, Turkey, 2022-2023) MS in Medical Biochemistry (Ege University, 2014-2016) MS in Chemistry (Çanakkale Onsekiz Mart University, 2010-2012) BS in Biochemistry (Ege University, 2005-2010) Dr. UYGUN's research focuses on nanobioelectrochemical systems for disease diagnostics, specializing in impedimetric biosensors , CRISPR-dCas9 technology , and molecularly imprinted polymers . His work targets cancer biomarkers (prostate, liver), infectious diseases (HIV), and inflammatory conditions (Crohn's disease) through non-invasive sampling methods. His publication trend (2022-2025) reveals strategic evolution toward AI-integrated point-of-care diagnostics using MXenes, MOFs, and machine learning. Recent work emphasizes saliva/urine-based detection and mobile health integration , with significant contributions to CRISPR-based DNA sensing and environmental contaminant monitoring. Scientific recognition includes: Leaders in Innovation Fellowship (2017) He actively secures TÜBİTAK funding including the 2218 Post-Doctoral Research Grant and 2250 Graduate Scholarship Program. His projects span chemical detection technologies and medical biosensor development, with collaborations at Koç University and Clarkson University. Dr. UYGUN leads translational research in electrochemical diagnostics, evidenced by 29+ publications and an h-index of 16 (Google Scholar). His laboratory specializes in impedimetric sensor fabrication and nanomaterial functionalization , currently developing systems for HIV detection, prostate cancer screening, and fertility assessment through paper-based colorimetric platforms.

• Biosensors
• Electrochemical Impedance Spectroscopy
• Molecularly Imprinted Polymers
• +۴ مورد دیگر

Professor Faruk Yağci is a distinguished academic and clinical expert at Gaziantep University Faculty of Medicine, Department of Surgical Medical Sciences, specializing in Urology. With over 68 peer-reviewed publications and 4 book chapters, his work focuses on bladder cancer , kidney stone disease , prostate disorders , and minimally invasive surgical techniques , particularly in adult and pediatric populations. His research spans urodynamics , lithotripsy , laparoscopic procedures , and molecular mechanisms of renal tubular apoptosis . He has contributed to comparative studies on plasmakinetic vs. monopolar transurethral resection and endourological management of pediatric urolithiasis . Notably, he has collaborated with Dr. Mehmet Sakip Erturhan and Dr. Ömer Bayrak on multi-center trials. Professor Yağci has supervised multiple thesis projects, including studies on prostate-specific antigen derivatives and GnRH agonists in metastatic prostate cancer . His clinical leadership extends to complication analysis in radical nephrectomy and cost-effectiveness evaluations of surgical interventions.

• Urology
• Endourology
• Kidney Stones
• +۴ مورد دیگر

Dr. Ayşegül Doğan is an Associate Professor in the Department of Genetics and Bioengineering at Yeditepe University's Faculty of Engineering, with promotion to full Professor scheduled for 2025. Her academic journey began with dual undergraduate degrees in Biology and Molecular Biology and Genetics at Istanbul University, followed by Master's and PhD studies in Biotechnology at Yeditepe University. Her educational background includes: PhD in Biotechnology (2011-2015), Yeditepe University - Thesis: "A novel chemotherapeutic drug combination for prostate cancer" Master's in Biotechnology (2009-2011), Yeditepe University - Thesis: "Effect of P85, F68 and F127 pluronic block copolymers on osteogenic, chondrogenic and adipogenic differentiation of human tooth germ stem cells (HTGSCs)" Undergraduate degrees in Biology and Molecular Biology and Genetics (2005-2009), Istanbul University Dr. Doğan's research spans multiple frontiers of stem cell biology and regenerative medicine. Her work particularly focuses on: Stem cell differentiation mechanisms and signaling pathways Organoid development for regenerative medicine applications Boron compounds in wound healing and tissue regeneration Cancer treatment using novel drug combinations Stem cell applications in reproductive medicine and endocrinology Analysis of her recent publications reveals an increasing emphasis on stem cell-derived organoids, with particular expertise in parathyroid function, adipose tissue engineering, and neural differentiation. Her research demonstrates sophisticated approaches to creating functional tissue models from pluripotent stem cells, with strong translational potential. Her scientific recognition includes: Multiple patents related to stem cell technology and wound healing formulations Patent Bronze Medal from ISIF and Turkish Patent Institute TÜBA-GEBİP award from the Turkish Academy of Sciences Department and Faculty First Prizes from Istanbul University Dr. Doğan actively mentors graduate students, with seven Master's and PhD theses completed under her supervision in recent years. She serves as principal investigator for multiple research projects funded by TÜBİTAK and other institutions, with current work focusing on stem cell applications in regenerative medicine. Her laboratory develops novel stem cell-based therapies and tissue engineering approaches, with particular emphasis on neuromesodermal progenitors and their therapeutic applications. She maintains active membership in professional organizations including the London Stem Cell Network, AACR, and the International Society for Stem Cell Research (ISSCR).

• Biology
• Molecular Biology
• Cell Biology
• +۵ مورد دیگر

Tuğba Bağcı Önder is a Professor in the Medical Biology department at Koç University's Graduate School of Health Sciences. Her work focuses on brain tumors, tumor cell apoptosis, and neural stem cells. She earned her PhD from Tufts University (2008) and Bachelor's from Bilkent University (2002). Key Research Areas : Brain Tumors, Molecular Mechanisms of Apoptosis, Neural Stem Cells Awards : BAGEP Award (2014), UNESCO-L’oreal Women in Science (2013) Her recent publications highlight epigenetic vulnerabilities in glioblastoma, prostate cancer, and breast cancer, with a focus on chromatin modifiers like BRPF1, KDM6A/B, and SWI/SNF dependencies. Therapeutic approaches include CRISPR screening, histone demethylase inhibition, and engineered stem cells. Scientific Awards BAGEP Award (2014) UNESCO-L’oreal for Women in Science in Turkey (2013)

• Brain Tumors
• Molecular Oncology
• Apoptosis Mechanisms
• +۳ مورد دیگر

Prof. Dr. Ramazan KOCAASLAN is a Professor in the Department of Urology, Faculty of Medicine at Kafkas University. His academic journey includes a Bachelor's from Istanbul University Cerrahpasa Faculty of Medicine (1995-2003), a medical specialization from Istanbul Training and Research Hospital (2003-2008), and an Associate Degree in Law from Anadolu University (2017-2020). He holds certifications in robotic surgery (Da Vinci) and multilingual proficiency (English YDS:71, German YDS:83). His research focuses on urological conditions including urolithiasis, benign prostatic hyperplasia, erectile dysfunction, and minimally invasive surgical techniques. He explores innovative diagnostic and therapeutic approaches, often incorporating pharmacological and surgical interventions. KOCAASLAN's publications emphasize evidence-based urology, with recent work analyzing surgical techniques for kidney stones, biomarkers for urinary infections, and medical therapies for urological disorders. His research frequently employs randomized trials and retrospective analyses to evaluate clinical outcomes. Awards & Honors: TÜYK Sertifikası (Turkish Urology Association, 2009) THE GPIU Study (European Association of Urology, 2008) EUREP (European Urology Residents Education Programme, 2006) He has led one major research project on renal cell carcinoma biomarkers (2013-2015) and collaborates extensively with urology researchers nationally. No formal advising roles or lab affiliations are documented.

• Urology
• Urolithiasis
• Benign Prostatic Hyperplasia
• +۳ مورد دیگر

Nathan Lack serves as an Associate Professor in the Department of Medical Pharmacology within the School of Medicine at Koç University, where he conducts research at the intersection of pharmacology and oncology. His academic foundation includes: PhD from Oxford University (2009) Bachelor's degree from the University of British Columbia (2004) Dr. Lack's research program centers on Drug Development targeting Nuclear Receptors, with significant emphasis on Functional Genomics approaches to understand Prostate Cancer pathogenesis. His work integrates molecular pharmacology with genomic technologies to identify novel therapeutic targets and mechanisms in cancer progression, particularly focusing on nuclear receptor signaling pathways in prostate malignancies. His scientific excellence has been recognized through prestigious awards: VCHRI Rising Star Scientific Award for early-career research impact Lorne Sullivan Best Basic Science Research Award for fundamental contributions to medical science While specific grant details and student mentoring records aren't documented in available sources, his research profile suggests active involvement in translational cancer pharmacology with potential industry and clinical collaborations within Koç University's medical ecosystem.

• Drug Development
• Nuclear Receptors
• Functional Genomics
• +۱ مورد دیگر